The significance of machine learning in neonatal screening for inherited metabolic diseases
Frontiers in Pediatrics · 20.03.2024 · 12
DOI: 10.3389/fped.2024.1366891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 20.03.2024. Verfasst von Xiangchun Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Central Laboratory of Birth Defects Prevention and Control, Ningbo Women and Children's Hospital, Ningbo City, Zhejiang, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neonatal screening for inherited metabolic diseases (IMDs) has been revolutionized by tandem mass spectrometry (MS/MS). This study aimed to enhance neonatal screening for IMDs using machine learning (ML) techniques.
Methods
The study involved the analysis of a comprehensive dataset comprising 309,102 neonatal screening records collected in the Ningbo region, China. An advanced ML system model, encompassing nine distinct algorithms, was employed for the purpose of predicting the presence of 31 different IMDs. The model was compared with traditional cutoff schemes to assess its diagnostic efficacy. Additionally, 180 suspected positive cases underwent further evaluation.
Results
The ML system exhibited a significantly reduced positive rate, from 1.17% to 0.33%, compared to cutoff schemes in the initial screening, minimizing unnecessary recalls and associated stress. In suspected positive cases, the ML system identified 142 true positives with high sensitivity (93.42%) and improved specificity (78.57%) compared to the cutoff scheme. While false negatives emerged, particularly in heterozygous carriers, our study revealed the potential of the ML system to detect asymptomatic cases.
Conclusion
This research provides valuable insights into the potential of ML in pediatric medicine for IMD diagnosis through neonatal screening, emphasizing the need for accurate carrier detection and further research in this domain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Central Laboratory of Birth Defects Prevention and Control, Ningbo Women and Children's Hospital, Ningbo City, Zhejiang, China.
- Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China.
- Department of Endocrinology, Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China.
- Department of Children's Healthcare Clinic, Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.
- Paediatric Surgery Centre, Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.
Zitieren
APA
Yang, X., Ding, S., Zhang, J., Hu, Z., Zhuang, D., Wang, F., Wu, S., Chen, C., & Li, H. (2024). The significance of machine learning in neonatal screening for inherited metabolic diseases. Frontiers in Pediatrics, 12. https://doi.org/10.3389/fped.2024.1366891
Vancouver
Yang X, Ding S, Zhang J, Hu Z, Zhuang D, Wang F, et al. The significance of machine learning in neonatal screening for inherited metabolic diseases. Frontiers in Pediatrics. 2024;12. doi:10.3389/fped.2024.1366891
BibTeX
@article{Yang2024,
author = {Yang, Xiangchun and Ding, Shuxia and Zhang, Jianping and Hu, Zhuojie and Zhuang, Danyan and Wang, Fei and Wu, Shanshan and Chen, Changshui and Li, Haibo},
title = {The significance of machine learning in neonatal screening for inherited metabolic diseases},
journal = {Frontiers in Pediatrics},
year = {2024},
volume = {12},
doi = {10.3389/fped.2024.1366891}
}
EUVIMED